Drugs / GLP-1 CellBeads
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01298830 | Oct 2008 → Jun 2011 | intracerebral hemorrhage | CellMed AG, a subsidiary of BTG plc. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GLP-1 CellBeads | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01298830 ↗ |
| Modality | Cell therapy | “alginate microcapsules containing allogenic mesenchymal cells” NCT01298830 ↗ |
| Route | Other | “By implantation into brain tissue cavity after surgical evacuation of the hematoma” NCT01298830 ↗ |